| U.S. Food and Drug Administration |
FDA MedWatch Program, May 23, 2003
Voluntary Recall of Viga Tablets
Best Life International is warning its consumers not to purchase or consume the product
known as Viga. This product which is being marketed as a dietary supplement
contains the unlabeled drug ingredient sildenafil, which may pose possible
serious health risks to some users. Viga is sold in bottles of 30 tablets which
are distributed by Best Life International Inc. This product is being promoted
for increasing desire, confidence and sexual performance. The product is sold
without medical prescription.
The interaction between nitrates and sildenafil can result in profound and
life-threatening lowering of blood pressure. The use of nitrates in any form is
an absolute contraindication for sildenafil users. The potential for this
product to be taken by unknowing nitrate users is real, since erectile
dysfunction is often a concurrent condition in patients with diabetes,
hypertension, hyperlipidemia, smokers and patients with ischemic heart
disease.
Consumers who have purchased Viga tablets are urged to immediately
discontinue their use and return to their place of purchase or directly to Best
Life International Inc. at Reparto Antillano, Calle 1ra # 188, Mayaguez, PR
00680. Consumers with questions regarding this recall may contact the company at
1-787-832-3287. Consumers who have purchased this product and have medical
concerns should consult with their health care providers.
Any adverse reactions experienced with the use of this product should be
reported to: U.S. Food and Drug Administration, San Juan District at
1-800-FDA-0127 or FDA’s Medwatch Program at 1-800-FDA-1088, by Fax at
1-800-FDA-0178, or by mail at MedWatch, FDA, 5600 Fishers Lane, Rockville, MD
20852-9787
This recall is being made in cooperation with the U.S. Food and Drug
Administration.
This advisory was prepared by the FDA MedWatch Program.
The text is a press release from Best Life International, Inc.